- Home
- NEGG vs TIL Comparison
NEGG vs TIL Comparison
Compare NEGG & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- TIL
- Stock Information
- Founded
- NEGG 2001
- TIL 2018
- Country
- NEGG United States
- TIL United States
- Employees
- NEGG N/A
- TIL N/A
- Industry
- NEGG Other Specialty Stores
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- NEGG Consumer Discretionary
- TIL Health Care
- Exchange
- NEGG Nasdaq
- TIL Nasdaq
- Market Cap
- NEGG 122.3M
- TIL 145.8M
- IPO Year
- NEGG 2010
- TIL 2021
- Fundamental
- Price
- NEGG $64.68
- TIL $23.22
- Analyst Decision
- NEGG
- TIL Buy
- Analyst Count
- NEGG 0
- TIL 5
- Target Price
- NEGG N/A
- TIL $119.00
- AVG Volume (30 Days)
- NEGG 1.3M
- TIL 232.2K
- Earning Date
- NEGG 08-28-2025
- TIL 08-12-2025
- Dividend Yield
- NEGG N/A
- TIL N/A
- EPS Growth
- NEGG N/A
- TIL N/A
- EPS
- NEGG N/A
- TIL N/A
- Revenue
- NEGG $1,235,576,000.00
- TIL N/A
- Revenue This Year
- NEGG N/A
- TIL N/A
- Revenue Next Year
- NEGG N/A
- TIL N/A
- P/E Ratio
- NEGG N/A
- TIL N/A
- Revenue Growth
- NEGG N/A
- TIL N/A
- 52 Week Low
- NEGG $3.32
- TIL $9.85
- 52 Week High
- NEGG $69.50
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- NEGG 67.17
- TIL 42.06
- Support Level
- NEGG $25.49
- TIL $25.58
- Resistance Level
- NEGG $69.50
- TIL $32.40
- Average True Range (ATR)
- NEGG 9.01
- TIL 2.80
- MACD
- NEGG 2.65
- TIL -0.65
- Stochastic Oscillator
- NEGG 89.05
- TIL 8.32
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.